204 related articles for article (PubMed ID: 10920938)
21. [Clinical value of serum tissue polypeptide specific antigen detection for primary hepatic cancer].
Huang DR; Zuo Q; Cai HB; Zhang JY; Ji CY
Di Yi Jun Yi Da Xue Xue Bao; 2005 Jan; 25(1):89-92. PubMed ID: 15684008
[TBL] [Abstract][Full Text] [Related]
22. Diagnostic procedures in the evaluation of hepatic diseases. Functional evaluation: carcinoembryonic antigen (CEA) and alphafetoprotein (AFP) as tumor markers of the liver.
Barroso A; Alpert E
Lab Res Methods Biol Med; 1983; 7():153-7. PubMed ID: 6194396
[No Abstract] [Full Text] [Related]
23. Canalicular immunostaining of aminopeptidase N (CD13) as a diagnostic marker for hepatocellular carcinoma.
Röcken C; Licht J; Roessner A; Carl-McGrath S
J Clin Pathol; 2005 Oct; 58(10):1069-75. PubMed ID: 16189153
[TBL] [Abstract][Full Text] [Related]
24. Combination of alpha-1-acid glycoprotein and alpha-fetoprotein as an improved diagnostic tool for hepatocellular carcinoma.
Bachtiar I; Santoso JM; Atmanegara B; Gani RA; Hasan I; Lesmana LA; Sulaiman A; Gu J; Tai S
Clin Chim Acta; 2009 Jan; 399(1-2):97-101. PubMed ID: 18926809
[TBL] [Abstract][Full Text] [Related]
25. [Clinical significance and diagnostic value of Golgi-protein 73 in patients with early-stage primary hepatocellular carcinoma].
Bao YX; Yang Y; Zhao HR; Mao R; Xiao L; Zhang YF; Aisiker T; Wen H
Zhonghua Zhong Liu Za Zhi; 2013 Jul; 35(7):505-8. PubMed ID: 24257301
[TBL] [Abstract][Full Text] [Related]
26. Significance of combined tests of serum golgi glycoprotein 73 and other biomarkers in diagnosis of small primary hepatocellular carcinoma.
Zhao Y; Wang M; Cui C; Zhang L; Liao F; Li H; Wu X
Cancer Biomark; 2015; 15(5):677-83. PubMed ID: 26406957
[TBL] [Abstract][Full Text] [Related]
27. [Detection and clinical study of serum tumor markers in patients with colorectal cancer].
Zhao XW; Jiang B; Han CZ; Jing JX
Zhonghua Zhong Liu Za Zhi; 2005 May; 27(5):286-8. PubMed ID: 15996321
[TBL] [Abstract][Full Text] [Related]
28. [Clinical value of combined detection of serum tumor markers in lung cancer diagnosis].
Chen F; Li WM; Wang DM; Gao SS; Bao Y; Chen WB; Liu D
Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Sep; 39(5):832-5. PubMed ID: 19024326
[TBL] [Abstract][Full Text] [Related]
29. Influence of cardiopulmonary resuscitation on levels of tumour markers.
Berent R; Auer J; Porodko M; Lamm G; Weber T; Wimmer E; Seier J; Aspöck G; Eber B
Eur J Cancer Care (Engl); 2006 Jul; 15(3):252-6. PubMed ID: 16882121
[TBL] [Abstract][Full Text] [Related]
30. [Tumor markers of hepatocellular carcinoma with special reference to diagnostic efficacy of combination of these markers and relation to its stages].
Sawabu N; Wakabayashi T; Ozaki K; Toya D; Yoneshima M
Gan No Rinsho; 1983 May; 29(6):672-7. PubMed ID: 6192267
[TBL] [Abstract][Full Text] [Related]
31. Serum AFU, GGT and TK1 levels in PHC patients and their correlation with clinicopathology and diagnostic value.
Gong G; Zheng K; Xue S; Hou J; Zhang Q
Cell Mol Biol (Noisy-le-grand); 2020 Jul; 66(5):111-116. PubMed ID: 33040823
[TBL] [Abstract][Full Text] [Related]
32. Combined use of established and novel tumour markers in the diagnosis of head and neck squamous cell carcinoma.
Ayude D; Gacio G; Páez de la Cadena M; Pallas E; Martínez-Zorzano VS; de Carlos A; Rodríguez-Berrocal FJ
Oncol Rep; 2003; 10(5):1345-50. PubMed ID: 12883705
[TBL] [Abstract][Full Text] [Related]
33. [Evaluation of detecting 9 tumor markers in serum for diagnosis of primary liver cancer].
Zeng XM
Zhonghua Zhong Liu Za Zhi; 1993 Nov; 15(6):427-30. PubMed ID: 8200280
[TBL] [Abstract][Full Text] [Related]
34. Normal and modified urinary nucleosides represent novel biomarkers for colorectal cancer diagnosis and surgery monitoring.
Feng B; Zheng MH; Zheng YF; Lu AG; Li JW; Wang ML; Ma JJ; Xu GW; Liu BY; Zhu ZG
J Gastroenterol Hepatol; 2005 Dec; 20(12):1913-9. PubMed ID: 16336453
[TBL] [Abstract][Full Text] [Related]
35. Significance of alpha-fetoprotein and des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma undergoing hepatectomy.
Yamamoto K; Imamura H; Matsuyama Y; Hasegawa K; Beck Y; Sugawara Y; Makuuchi M; Kokudo N
Ann Surg Oncol; 2009 Oct; 16(10):2795-804. PubMed ID: 19669841
[TBL] [Abstract][Full Text] [Related]
36. Clinical performance of α-L-fucosidase for early detection of hepatocellular carcinoma.
Xing H; Qiu H; Ding X; Han J; Li Z; Wu H; Yan C; Li H; Han R; Zhang H; Li C; Wang M; Wu M; Shen F; Zheng Y; Yang T
Biomark Med; 2019 May; 13(7):545-555. PubMed ID: 31140827
[No Abstract] [Full Text] [Related]
37. The significance of ferritin, lipid-associated sialic acid, CEA, squamous cell carcinoma (SCC) antigen, and CYFRA 21-1 levels in SCC of the head and neck.
Inal E; Laçin M; Asal K; Ceylan A; Köybaşioğlu A; Ileri F; Uslu SS
Kulak Burun Bogaz Ihtis Derg; 2004; 12(1-2):23-30. PubMed ID: 16010093
[TBL] [Abstract][Full Text] [Related]
38. Sensitivity and specificity of des-gamma-carboxy prothrombin for diagnosis of patients with hepatocellular carcinomas varies according to tumor size.
Nakamura S; Nouso K; Sakaguchi K; Ito YM; Ohashi Y; Kobayashi Y; Toshikuni N; Tanaka H; Miyake Y; Matsumoto E; Shiratori Y
Am J Gastroenterol; 2006 Sep; 101(9):2038-43. PubMed ID: 16848811
[TBL] [Abstract][Full Text] [Related]
39. [Detection of GGT-II by dot-ELISA with monoclonal antibody in the diagnosis of hepatocellular carcinoma].
Ni RZ; Huang JF; Xiao MB; Zhang PY; Meng XY
Ai Zheng; 2004 Jan; 23(1):66-8. PubMed ID: 14720378
[TBL] [Abstract][Full Text] [Related]
40. Prognostic significance of three hepatitis markers (p53 antibodies, vascular endothelial growth factors and alpha fetoprotein) in patients with hepatocellular carcinoma.
Gadelhak NA; Gadelhak SA; El-Morsi DA; Abdelaziz MM; Abbas AT; El-Emshaty HM
Hepatogastroenterology; 2009; 56(94-95):1417-24. PubMed ID: 19950803
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
